FloraGLO had been steadily losing market share, when a new patent offered them a huge marketing opportunity to formally position themselves as a source of protection against blue light. Every year, people spend more time glued to their smartphones, TVs and tablets, all emitting harmful blue light. And while many people have experienced dry eyes, blurred vision and headaches, most are unaware of the long-term effects like retinal damage, increased risk of cancer and macular degeneration.
GKV worked with Kemin to create and launch an awareness campaign designed to increase consumer purchasing of supplements containing FloraGLO and to educate consumers on the importance of blue-light protection.
Thanks to the success of the campaign, FloraGLO had a record 2017, with sales increasing by 6.5% compared to the previous year.